The Institute encourages research that improves understanding of the complex pathogen, host, environment interactions that fuel the emergence and spread of infectious diseases.
Congratulations to the following applicants who were successful in the 2022 seed funding round. We look forward to hearing about the research outcomes in the coming year.
|Interferon alpha treatment to reactivate latent HIV
|Japanese Encephalitis in northern New South Wales
|A rapidly deployable vaccine platform generating CD4+ T cell responses to prevent economically important syndromic conditions in Australia livestock
|Delineating the risk factors and source of neonatal acquisition of multi-drug resistant Gram-negative pathogens in high burden countries in South-East Asia and the Pacific
|Modelling the impact of opinion dynamics on the COVID-19 pandemic in Australia
|Optimising youth-centred health communication via social media during COVID-19 and beyond.
|Investigating the therapeutic potential of a novel antiviral epigenetic factor in innate immunity and respiratory viral infection
|Virulome and resistome assessment of Group B Streptococcus in maternal colonisation and neonatal invasive disease
|Genomic Insights into Exotic and Indigenous Non-Typhoidal Salmonella Serovars of Significance to Public Health
|Genomic resolution of invasive non-typable Streptococcus pneumoniae using a hybridised assembly approach
|Genomic resolution of clinical Shiga toxin producing Escherichia coli isolated in New South Wales
Congratulations to the following applicants who were successful in the 2021 seed funding round. We look forward to hearing about the research outcomes in the coming year.
|Mucosal vaccination against SARS-CoV-2 to generate protection in the upper respiratory tract
|Mapping phage biodistribution and imaging infection using PET
|Hybrid Iron-Gold Nanoflowers as a Novel Protein-based Vaccine Platform: a Further Step Towards Universal Influenza and COVID-19 Vaccines
|Streamlining the treatment of urinary tract infections in children: A non-inferiority, pragmatic, adaptive trial to evaluate oral fosfomycin versus standard-of-care in children with multidrug-resistant infections
|Identifying immunotherapy candidates for enhancing CTL response against persistent HIV
|COVID-19 Outbreak Management within Disability Group Home and Residential Aged Care Facilities across Western Sydney: a Donabedian health evaluation
|Investigating links between antibiotic resistance and heavy metal resistance genes in plasmid genomes and metagenomes
|Developing a genomic toolkit for understanding Hendra virus disease
|Yoon Kyung (Rachel) Chang
|Targeting intracellular Chlamydial infections in koalas by liposome-encapsulated bacteriophages
|Investigation of the prevalence of SARS-CoV-2 infection and the related preventive measures and risk factors in 2022 Arbaeen mass gathering
|Improved effectiveness of vector identification: Implications for surveillance of mosquito-borne pathogens and associated vector species
|CDK function and potential as a novel pan-fungal drug target
|Immune responses following SARS C0V-2 vaccines in Australian children
Congratulations to the following applicants who were successful in the 2020 seed funding round. We look forward to hearing about the research outcomes in the coming year.
|Therapeutic targeting of TGF-β and Smad3 in SARS-CoV-2 infection
|Respiratory Tract Infections
|Tracking medically relevant Legionella pneumophila to aid outbreak control
|Nanopore Sequencing using the Flongle as fast diagnostic tool for direct diagnosis of mycosis from clinical samples
|Video camera technology for auditing and monitoring healthcare worker infection prevention and control practices for COVID-19 and other high-consequence infectious diseases: An exploratory and evaluative study
|Ethics and Politics of Infection
|Assessing the zoonotic potential of Candida species in Vietnamese chicken farms
|The return of a zoonotic disease - Leptospirosis in Sydney and the role of rats in disease "hot spots"
|Hand hygiene to reducing respiratory-tract infection transmission among Hajj pilgrims: a feasibility trial (Project HHRTIHajj)
|Tracking phage-bacteria dynamics in vivo using fluorescence
|AMR - Precision ID
|Integrating mycobiome and microbiome analyses in studies of the interplay between soil, vegetation and livestock
|Saliva-based precision dosing in children using fluconazole as a model to explore feasibility
This large-scale funding opportunity is specifically aimed at groups that are driven by strong preliminary data and collaboration. Projects up to $50,000 will be funded and must be concluded within 1-2 years.
Submissions will be evaluated using a double-stage procedures. Initially screening will be performed by an executive team to ensure that the objectives and minimum quality criteria are met. Then a multidisciplinary advisory board, composed of members from major schools and disciplines will consider the strategic importance and strength of the application.
Contact us to find out more about applying for this funding call.